AVEVRO AVEVRO

Select your language

  • English
  • Arabic (اللغة العربية)
  • Русский (Россия)
  • Français (France)
  • 简体中文
  • 日本語 (Japan)

CONTACT US

  • Home
  • Treatments
    • Explore All Treatments
    • Cancer Care
    • Heart & Vascular Care
    • Neurology & Neurosurgery
    • Orthopedic Care
  • Hospitals & Specialists
    • Find a Hospital
    • Find a Specialist
    • Hospitals by Location
    • Specialists by Medical Field
    • Quality & Accreditation
  • Patient Services
    • How It Works
    • Submit Medical Records
    • Treatment Plans & Costs
    • Travel & Visa Support
    • Patient FAQs
  • About Us
    • Why Choose Us
    • Why China
    • Patient Experiences
    • Global Partners
    • Contact Our Team
  • Register for an account
  • I forgot my username
  • I forgot my password
AVEVRO AVEVRO
  • Home
  • Treatments

    Featured Care

    • Cancer Care
    • Heart & Vascular Care

    More Specialties

    • Neurology & Neurosurgery
    • Orthopedic Care
    • Explore All Treatments
  • Hospitals & Specialists

    Hospitals

    • Find a Hospital
    • Hospitals by Location
    • Quality & Accreditation

    Medical Specialists

    • Find a Specialist
    • Specialists by Medical Field
  • Patient Services

    Start Your Journey

    • How It Works
    • Submit Medical Records
    • Treatment Plans & Costs

    Travel & Support

    • Travel & Visa Support
    • Patient FAQs
  • About Us

    About Our Network

    • Why Choose Us
    • Why China
    • Global Partners

    Patients & Contact

    • Patient Experiences
    • Contact Our Team

Contact Us

Details
Parent Category: Case Studies
Last Updated: 30 September 2026
Hits: 522

C.H., Epilepsy (Seizure Disorder) - Norway

About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.

Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.

Case Study: Epilepsy (Seizure Disorder)

 
 
 

Patient Information:

  • Name: Cecille Horgen
  • Diagnosis: Seizure Disorder (Epilepsy)
  • Date of Birth (D.O.B): January 1, 1990
  • Gender: Female
  • Country: Norway

Treatment: Minimally Invasive Brain Surgery for Seizure Disorder (Functional Stereotaxy) with Daily Intravenous (IV) Neurological Nutritional Support, Neural Growth Factors Injection, Neural Cell Activation & Proliferation Therapy, and Rehabilitation Therapy

History:
Cecille Horgen, a 24-year-old woman from Norway, was admitted to Beijing Puhua International Hospital due to "intermittent seizures for 17 years and no speech communication for 5 years." She had previously undergone surgery at the age of eight to remove an arachnoid cyst in her right ventricle. Although the operation initially resolved her condition, Cecille subsequently developed a seizure disorder and lost most of her language skills.

Medical Condition Before Minimally Invasive Brain Surgery:
Prior to stereotactic treatment, Cecille had not spoken for five years. She maintained a stiff and straight body posture with her hands on her legs (both awake and asleep). She did not communicate verbally or make eye contact with her family members. She was highly sensitive and anxious around strangers.

Minimally Invasive Brain Surgery:
Cecille underwent stereotactic destruction of the nucleus with injections of neural growth factors, neural cell activation & proliferation therapy, and rehabilitation therapy.

Medical Condition After Minimally Invasive Brain Surgery:
Following stereotactic therapy for seizure disorder:

  • Cecille's seizure frequency significantly decreased.
  • She started speaking to her mother and sister soon after treatment.
  • Became more cooperative during Traditional Chinese Medicine (TCM) therapy, rehabilitation therapy, and the stereotactic procedure itself.
  • Showed increased flexibility and relaxation in movement, with improved ability to perform exercises like playing ball, riding a bicycle, and running on a treadmill.
  • Began speaking occasionally with others besides her mother, displaying more natural emotional expressions, stable mood, and improved body posture both day and night.
  • Her sleep duration increased from 2-3 hours to 8-10 hours daily.

Follow-Up:
18 February 2011 – Cecille's family reported that her seizures had become significantly less frequent. She also started speaking more often, demonstrating increased mental clarity, expressiveness, and an overall improvement in her general situation since undergoing Stereotactic Therapy at Beijing Puhua International Hospital.

  • Norway
  • Epilepsy (Seizure Disorder)
Email & Social

[email protected]

AVEVRO

Care in China, coordinated around you.

Independent guidance for international patients seeking appropriate specialists, hospitals and a clearer route through treatment abroad.

About our coordination service →
Explore
All treatments ↗Cancer care ↗Heart & vascular ↗Neurological care ↗Orthopedic care ↗
Start your inquiry

Share your medical records securely.

Our international coordination team will help identify the appropriate next step.

Request a medical review →[email protected]
QR code to contact AVEVROScan to connect

Select your language

  • English
  • Arabic (اللغة العربية)
  • Русский (Россия)
  • Français (France)
  • 简体中文
  • 日本語 (Japan)
Legal & Privacy
  • Privacy Policy
  • Terms of Service
  • Cookie Policy
Copyright © 2026 AVEVRO. All Rights Reserved.
Cron Job Starts